Waters Corporation(WAT) Stock Research - Grey Stern Research
Loading...

Waters Corporation (WAT) Stock Analysis

$385.96 (-0.31%)

WAT Financial Performance


Use the table below to view Waters Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $387.34 -
52 Week Low $241.95 -
52 Week High $391.00 -
Market Cap $23.0 Billion 7/11
Gross Margin 58% 3/11
Profit Margin 20% 3/11
EBITDA margin 34% 3/11
Q2 - 2024 Revenue $708.5 Million 9/11
Q2 - 2024 Earnings $142.7 Million 7/11
Q2 - 2024 Free Cash Flow $18.4 Million 9/11
Trailing 4 Quarters Revenue $2.9 Billion 9/11
Trailing 4 Quarters Earnings $595.7 Million 6/11
Quarterly Earnings Growth -5% 4/11
Annual Earnings Growth 4% 6/11
Quarterly Revenue Growth -4% 8/11
Annual Revenue Growth 3% 4/11
Cash On Hand $326.4 Million 7/11
Short Term Debt $26.4 Million 8/11
Long Term Debt $2.0 Billion 7/11

Waters Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Waters Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 38.60 4/11
PS 7.99 4/11
PB 16.28 3/11
PC 70.44 3/11
Liabilities to Equity 2.15 4/11
ROA 0.13 3/11
ROE 0.42 2/11
Current Ratio 1.46 7/11
Quick Ratio 0.11 5/11
Long Term Debt to Equity 1.42 3/11
Debt to Equity 1.48 4/11
Burn Rate -5.84 10/11
Cash to Cap 0.01 8/11
CCR 0.13 8/11
EV to EBITDA 103.83 4/11
EV to Revenue 8.61 3/11

Company Details

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

CEO: Mr. Christopher O'Connell

Website: https://www.waters.com

Address: 34 MAPLE ST Milford, MASSACHUSETTS

Exchange: New York Stock Exchange

Industry: Diagnostics & Research

Waters Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Waters Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Danaher Corporation DHR $180.6 Billion
Thermo Fisher Scientific Inc. TMO $214.2 Billion
Illumina, Inc. ILMN $24.7 Billion
IDEXX Laboratories, Inc. IDXX $34.1 Billion
IQVIA Holdings Inc. IQV $38.6 Billion
Charles River Laboratories International, Inc. CRL $9.7 Billion
Mettler-Toledo International Inc. MTD $29.6 Billion
ICON Public Limited Company ICLR $18.7 Billion
Twist Bioscience Corporation TWST $2.5 Billion
Sotera Health Company SHC $4.4 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
WAT Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 740.3 Million $161.5 Million
Q2 2024 $ 708.5 Million $142.7 Million
Q1 2024 $ 636.8 Million $102.2 Million
Q4 2023 $ 819.5 Million $216.2 Million
Q3 2023 $ 711.7 Million $134.6 Million
Q2 2023 $ 740.6 Million $150.6 Million
Q1 2023 $ 684.7 Million $140.9 Million
Q3 2022 $ 708.6 Million $156.0 Million

View All

WAT Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $331.5 Million $4.5 Billion $25.3 Million $1.6 Billion
Q2 2024 $326.4 Million $4.4 Billion $2.1 Billion $1.4 Billion
Q1 2024 $337.3 Million $4.5 Billion $2.1 Billion $1.3 Billion
Q4 2023 $396.0 Million $4.6 Billion $0 $1.2 Billion
Q3 2023 $336.4 Million $4.5 Billion $2.6 Billion $905.5 Million
Q2 2023 $329.7 Million $4.5 Billion $2.7 Billion $771.2 Million
Q1 2023 $486.1 Million $3.3 Billion $1.5 Billion $599.8 Million
Q3 2022 $444.5 Million $3.1 Billion $0 $385.2 Million

View All

WAT Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $179.0 Million -$25.6 Million $4.1 Million
Q2 2024 $18.4 Million -$36.1 Million -$10.9 Million
Q1 2024 $234.2 Million -$28.7 Million -$57.8 Million
Q4 2023 $188.5 Million -$41.6 Million $58.7 Million
Q3 2023 $0 $0 $0
Q2 2023 -$28.5 Million -$46.6 Million -$156.4 Million
Q1 2023 $162.4 Million -$34.4 Million $5.5 Million
Q3 2022 $119.1 Million -$39.0 Million $24.7 Million

View All